Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

INTRODUCTION: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is known to be chemosensitive. In patients with TNBC, we sought to compare survival outcomes between patients receiving neoadjuvant chemotherapy, with and without complete pathologic response (pCR), and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fisher, Carla S., Ma, Cynthia X., Gillanders, William E., Aft, Rebecca L., Eberlein, Timothy J., Gao, Feng, Margenthaler, Julie A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3892697/
https://ncbi.nlm.nih.gov/pubmed/21725686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-011-1877-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados